Immunotherapy

October 9, 2023

Research dictionary entry

October 9, 2023

Categories

Trial Results

Trial Results: ECOG-ACRIN research round-up – Fall 2023

Summaries of recent publications by researchers affiliated with ECOG-ACRIN

January 5, 2023

January 5, 2023

Categories

Ongoing Trials

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)

January 5, 2023

Lung x-ray on iPad

January 5, 2023

Categories

Ongoing Trials

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether

January 5, 2023

Patient and doctor speaking in exam room

January 5, 2023

Categories

Trial Results

Trial Results: A recent ECOG-ACRIN study finds excellent results for patients with acute lymphoblastic leukemia (ALL)

Adding immunotherapy to standard chemotherapy keeps most patients in remission and improves their survival